World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 21 December 2015
Main ID:  NCT02031588
Date of registration: 07/01/2014
Prospective Registration: No
Primary sponsor: Assistance Publique - Hôpitaux de Paris
Public title: Impact of Ceftriaxone and/or Fluoroquinolone (FQ) Treatment on the Gut Microbiota of Hospitalized Patients. EVOTAR
Scientific title: Impact of Ceftriaxone and/or Fluoroquinolone (FQ) Treatment on the Gut Microbiota of Hospitalized Patients.
Date of first enrolment: December 2012
Target sample size: 77
Recruitment status: Terminated
URL:  https://clinicaltrials.gov/show/NCT02031588
Study type:  Observational
Study design:  Observational Model: Cohort, Time Perspective: Prospective  
Phase:  N/A
Countries of recruitment
France
Contacts
Name:     Victoire De Latours, Doctor
Address: 
Telephone:
Email:
Affiliation:  Assistance Publique - Hôpitaux de Paris
Key inclusion & exclusion criteria

Inclusion criteria for the patients treated with antibiotics

- Adult patient hospitalized in a participating ward of the hospital for an expected
duration of more than 24 hours.

- Treatment by ceftriaxone and / or a fluoroquinolone started by the attending
physicians during hospitalization.

- No hospitalization or stay in nursing home in the previous three months.

- No use of antibiotics in the last 3 months

- Not receiving other antibiotics than ceftriaxone or FQ

- Informed consent

Inclusion criteria for the patients in the reference group

- Adult patient hospitalized in a participating ward of the hospital for an expected
duration of more than 24 hours.

- Not receiving any antibiotic and not expected to receive any during hospitalization

- No hospitalization or stay in nursing home in the previous three months.

- No use of antibiotics in the last 3 months

- Informed consent

Exclusion criteria

- Pregnant or nursing women

- Patient who underwent colectomy or suffering from chronic intestinal disease
(inflammatory intestinal disease or short bowel syndrome)

- Patient who used a bowel preparation solution for colonoscopy during hospitalization
or in the previous week.

- Protected adult patient (deputyship or guardianship)



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Bacterial Infections
Intervention(s)
Primary Outcome(s)
Describe the changes in the composition of the gut microbial flora in relation to the initial flora (T0) in patients receiving antibiotics, by date of sampling, treatment received, dose, duration of therapy, ward, and duration of hospital stay. [Time Frame: 1 year]
Secondary Outcome(s)
A secondary endpoint is to describe the changes in the gut microbiota of hospitalized patients not receiving antibiotics. [Time Frame: 1 year]
Secondary ID(s)
RAFREU53
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history